# Wilson Disease Masquerading as Nephrotic Syndrome: A Case Report

**Authors:** Gaurav Gupta, Shabnam Kalita, Himel Mondal, Jaya Shankar Kaushik

PMC · DOI: 10.7759/cureus.86250 · Cureus · 2025-06-17

## TL;DR

A child with Wilson disease initially showed symptoms of nephrotic syndrome, highlighting the importance of early diagnosis and treatment for better outcomes.

## Contribution

This case report highlights the rare presentation of Wilson disease as nephrotic syndrome and emphasizes the need for early recognition.

## Key findings

- Nephrotic syndrome can be a rare initial manifestation of Wilson disease.
- Early diagnosis and treatment led to symptomatic and biochemical improvement in the patient.
- Multidisciplinary management is crucial for favorable outcomes in such cases.

## Abstract

Wilson disease (WD) is a rare, autosomal recessive disorder characterized by defective copper metabolism. Renal manifestations in WD are uncommon, and nephrotic syndrome as an initial presentation is rare. An eight-year-old boy presented with progressive abdominal distension and decreased urine output. Examination revealed pedal edema, ascites, and icterus. Investigations showed nephrotic range proteinuria, elevated liver enzymes, low serum ceruloplasmin, and Kayser-Fleischer rings, confirming a diagnosis of WD with associated nephrotic syndrome. WD presented with nephrotic syndrome and was confirmed by clinical findings, biochemical tests, and slit-lamp examination. The patient was started on oral penicillamine, zinc supplementation, hepatic support, and a copper-restricted diet. Subsequent follow-up showed symptomatic and biochemical improvement. Resolution of ascites and proteinuria was achieved, with stabilization of liver function. The patient was later managed for portal hypertension with spironolactone and propranolol. Hence, nephrotic syndrome can be a rare presenting feature of WD. Early recognition and multidisciplinary management are essential for favorable outcomes.

## Linked entities

- **Chemicals:** penicillamine (PubChem CID 4727), zinc (PubChem CID 23994), spironolactone (PubChem CID 5833), propranolol (PubChem CID 4946)
- **Diseases:** Wilson disease (MONDO:0010200), nephrotic syndrome (MONDO:0005377)

## Full-text entities

- **Genes:** CP (ceruloplasmin) [NCBI Gene 1356] {aka AB073614, CP-2}
- **Diseases:** proteinuria (MESH:D011507), copper metabolism (MESH:C535468), portal hypertension (MESH:D006975), WD (MESH:D006527), autosomal recessive disorder (MESH:D030342), icterus (MESH:D007565), Nephrotic Syndrome (MESH:D009404), abdominal distension (MESH:D000007), edema (MESH:D004487), ascites (MESH:D001201)
- **Chemicals:** propranolol (MESH:D011433), copper (MESH:D003300), spironolactone (MESH:D013148), zinc (MESH:D015032), penicillamine (MESH:D010396)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12271823/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12271823/full.md

## References

18 references — full list in the complete paper: https://tomesphere.com/paper/PMC12271823/full.md

---
Source: https://tomesphere.com/paper/PMC12271823